Rwir empfehlen dieses Produkt basierend auf den Präferenzen unserer Kunden.
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung | 
|---|---|---|---|---|---|---|---|
| CRBP I siRNA (h) | sc-43699 | h | Gene Silencing | N/A | 0 | ||
| CRBP I shRNA Plasmid (h) | sc-43699-SH | h | Gene Silencing | Puromycin | 0 | ||
| CRBP I shRNA (h) Lentivirale Partikel | sc-43699-V | h | Gene Silencing | Puromycin | 0 | ||
| CRBP I siRNA (m) | sc-60043 | m | Gene Silencing | N/A | 0 | ||
| CRBP I shRNA Plasmid (m) | sc-60043-SH | m | Gene Silencing | Puromycin | 0 | ||
| CRBP I shRNA (m) Lentivirale Partikel | sc-60043-V | m | Gene Silencing | Puromycin | 0 | ||
| CRBP II siRNA (h) | sc-78318 | h | Gene Silencing | N/A | 0 | ||
| CRBP II shRNA Plasmid (h) | sc-78318-SH | h | Gene Silencing | Puromycin | 0 | ||
| CRBP II shRNA (h) Lentivirale Partikel | sc-78318-V | h | Gene Silencing | Puromycin | 0 | ||
| CRBP II siRNA (m) | sc-142563 | m | Gene Silencing | N/A | 0 | ||
| CRBP II shRNA Plasmid (m) | sc-142563-SH | m | Gene Silencing | Puromycin | 0 | ||
| CRBP II shRNA (m) Lentivirale Partikel | sc-142563-V | m | Gene Silencing | Puromycin | 0 | ||
| CRBP III siRNA (h) | sc-60440 | h | Gene Silencing | N/A | 0 | ||
| CRBP III shRNA Plasmid (h) | sc-60440-SH | h | Gene Silencing | Puromycin | 0 | ||
| CRBP III shRNA (h) Lentivirale Partikel | sc-60440-V | h | Gene Silencing | Puromycin | 0 | ||
| CRBP IV siRNA (h) | sc-88028 | h | Gene Silencing | N/A | 0 | ||
| CRBP IV shRNA Plasmid (h) | sc-88028-SH | h | Gene Silencing | Puromycin | 0 | ||
| CRBP IV shRNA (h) Lentivirale Partikel | sc-88028-V | h | Gene Silencing | Puromycin | 0 | ||
| CRBP IV (h)-PR | sc-88028-PR | h | Primer | N/A | 0 | ||
| CRBP IV siRNA (m) | sc-105244 | m | Gene Silencing | N/A | 0 | ||
| CRBP IV shRNA Plasmid (m) | sc-105244-SH | m | Gene Silencing | Puromycin | 0 | ||
| CRBP IV shRNA (m) Lentivirale Partikel | sc-105244-V | m | Gene Silencing | Puromycin | 0 | ||
| CRBP IV (m)-PR | sc-105244-PR | m | Primer | N/A | 0 |